SecSonar.com

Beta Bionics, Inc. (BBNX)

Beta Bionics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Beta Bionics, Inc. (BBNX) is a Medical - Equipment & Services company based in US with a market capitalization of $539.2M. Revenue grew 53.9% year-over-year and free cash flow was negative at -$56.2M. This page tracks BBNX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 352 employees · IPO Jan 30, 2025

Valuation

Valuation & price

$9.46 · as of May 17, 2026 · -70.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.87

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$31.99$20.59$9.20Jul 25Dec 25Jun 26Jul 7, 25$13.40Jul 9, 25$13.28Jul 11, 25$12.67Jul 15, 25$12.53Jul 17, 25$13.17Jul 21, 25$14.30Jul 23, 25$14.77Jul 25, 25$14.84Jul 29, 25$14.66Jul 31, 25$16.79Aug 4, 25$16.42Aug 6, 25$15.20Aug 8, 25$14.74Aug 12, 25$14.22Aug 14, 25$16.71Aug 18, 25$17.26Aug 20, 25$15.30Aug 22, 25$17.05Aug 27, 25$18.97Aug 29, 25$18.84Sep 3, 25$19.68Sep 5, 25$20.20Sep 9, 25$25.00Sep 11, 25$25.34Sep 15, 25$25.31Sep 17, 25$23.11Sep 19, 25$22.46Sep 23, 25$22.87Sep 25, 25$22.13Sep 29, 25$19.86Oct 1, 25$20.21Oct 3, 25$22.26Oct 7, 25$22.15Oct 9, 25$22.23Oct 13, 25$22.15Oct 16, 25$20.63Oct 20, 25$20.24Oct 22, 25$21.22Oct 24, 25$20.95Oct 28, 25$24.28Oct 30, 25$26.78Nov 3, 25$27.71Nov 5, 25$26.51Nov 7, 25$26.30Nov 11, 25$28.82Nov 13, 25$26.24Nov 17, 25$27.16Nov 19, 25$27.72Nov 21, 25$31.42Nov 25, 25$31.51Nov 28, 25$31.34Dec 2, 25$28.44Dec 5, 25$29.38Dec 9, 25$29.01Dec 11, 25$29.31Dec 15, 25$29.72Dec 17, 25$29.19Dec 19, 25$29.25Dec 23, 25$31.35Dec 26, 25$31.86Dec 30, 25$31.97Jan 2, 26$29.25Jan 6, 26$31.40Jan 8, 26$31.99Jan 12, 26$17.65Jan 14, 26$16.99Jan 16, 26$18.50Jan 21, 26$16.47Jan 23, 26$15.96Jan 28, 26$14.78Jan 30, 26$13.83Feb 3, 26$14.46Feb 5, 26$13.24Feb 9, 26$13.87Feb 11, 26$14.12Feb 13, 26$13.94Feb 18, 26$13.61Feb 20, 26$13.70Feb 24, 26$13.39Feb 26, 26$13.02Mar 2, 26$12.52Mar 4, 26$11.38Mar 6, 26$10.61Mar 10, 26$10.97Mar 12, 26$10.11Mar 16, 26$10.87Mar 19, 26$10.80Mar 23, 26$11.02Mar 25, 26$11.31Mar 27, 26$10.76Mar 31, 26$10.02Apr 2, 26$9.93Apr 7, 26$9.73Apr 9, 26$9.63Apr 13, 26$10.63Apr 15, 26$13.02Apr 17, 26$12.98Apr 21, 26$12.27Apr 23, 26$11.43Apr 27, 26$10.65Apr 29, 26$9.90May 1, 26$10.29May 5, 26$10.01May 8, 26$9.65May 12, 26$9.82May 14, 26$9.20May 18, 26$9.40May 20, 26$10.11May 22, 26$11.82May 27, 26$11.63May 29, 26$12.12Jun 2, 26$12.79Jun 4, 26$13.89Jun 8, 26$13.87Jun 10, 26$13.72Jun 12, 26$14.53Jun 16, 26$13.95Jun 18, 26$13.88Jun 23, 26$13.67Jun 29, 26$17.00
$8.8652-week range$31.99
Loading valuation history…

Fundamentals

Key fundamentals

$539.2M

Market cap

53.9%

Revenue growth (YoY)

55.4%

Gross margin

-$56.2M

Free cash flow (USD)

-$211.8M

Net debt

Net cash position

536.7%

Share dilution

2/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2022 → 2025

FY 2022$179.0KFY 2023$12.0MFY 2024$65.1MFY 2025$100.3M
$179K$100.3M

Free cash flow by year

2022 → 2025

FY 2022$-61.0MFY 2023$-32.8MFY 2024$-51.7MFY 2025$-56.2M
-$61M-$56.2M

Gross margin by year

2022 → 2025

FY 2022100.0%FY 202352.6%FY 202455.1%FY 202555.4%
100.0%55.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

13

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 21, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $170K · 10b5-1 PlanFeider Stephen · Chief Financial Officer · $170.4KJul 2, 2026Filing
  • Insider sellInsider Sell $170K · 10b5-1 PlanFeider Stephen · Chief Financial Officer · $170.4KJun 30, 2026Filing
  • Insider sellInsider Sell $21K · 10b5-1 PlanJones Christy · Director · $21.1KJun 25, 2026Filing
  • Insider sellInsider Sell $19K · 10b5-1 PlanHopman Mark · Chief Commercial Officer · $18.9KJun 25, 2026Filing
  • Insider sellInsider Sell $39K · 10b5-1 PlanJones Christy · Director · $39.4KJun 5, 2026Filing
  • Insider sellInsider Sell $3K · 10b5-1 PlanHopman Mark · Chief Commercial Officer · $3.4KJun 5, 2026Filing
  • Insider sellInsider Sell $213KSaint Sean · Director, President & CEO · $212.7KJun 3, 2026Filing
  • Insider sellInsider Sell $84KFeider Stephen · Chief Financial Officer · $84.2KJun 3, 2026Filing
  • Insider sellInsider Sell $53KRussell Steven Jon · Chief Medical Officer · $53.2KJun 3, 2026Filing
  • Insider sellInsider Sell $67KHopman Mark · Chief Commercial Officer · $67.2KJun 3, 2026Filing

Questions

Frequently asked questions

What is Beta Bionics, Inc.'s market cap?

Beta Bionics, Inc. (BBNX) has a market capitalization of $539.2M.

What is BBNX's P/E ratio?

A meaningful P/E ratio is not available for BBNX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is BBNX's price-to-book (P/B) ratio?

BBNX trades at 1.87 times book value per share.

Are insiders buying BBNX stock?

SEC Form 4 filings show no open-market insider buys at Beta Bionics, Inc. in the last 90 days (13 sells).

Same arena

Related companies in Medical - Equipment & Services

PARK

Park Dental Partners, Inc. Common Stock

$37.1M

CON

Concentra Group Holdings Parent, Inc.

$3.2B

NVST

Envista Holdings Corp

$3.9B

HIMS

Hims & Hers Health, Inc.

$5.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.